Novartis’ Cholesterol Drug Inclisiran Closes In On EU Approval

Drug Will Be Known As Leqvio

 
• By Andrew McConaghie
  
Amsterdam, March 2020. Entrance of the office from the European Medicines Agency (EMA) in Amsterdam
The European Medicine Agency in Amsterdam.
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip